Trial intelligence / Profile preview

Effects of vitamin D on beta cell function and insulin sensitivity in pre-diabetes and type 2 diabetes (EVIDENS)

2010-024487-18Phase 2Completed

Sponsor
Karolinska University Hospital
Start
Apr 2011
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, randomised, double-blind trial in impaired fasting glucose (IFG), prediabetes, type 2 diabetes mellitus (T2DM) and 1 more comparing Vitamin D3 (Vigantol Oil) with Placebo (2 arms). Primary endpoint: Change in beta cell function at 8 weeks. Started Apr 2011; status: completed.

02

Drugs

cholecalciferol
03

Conditions

impaired fasting glucose (IFG)prediabetestype 2 diabetes mellitus (T2DM)Vitamin D deficiency (VDD)

Beyond the preview

Go deeper on 2010-024487-18.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2010-024487-18.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call